ASTEX PHARMACEUTICALS, INC Equity Method Investment, Aggregate Cost
ASTEX PHARMACEUTICALS, INC had Equity Method Investment, Aggregate Cost of $1.50 million as of 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentAggregateCost · last filed 2012-11-09
- 2012-09-30: Equity Method Investment, Aggregate Cost $1.50M.
| Period end | Equity Method Investment, Aggregate Cost |
|---|---|
| 2012-09-30 | $1.50M 10-Q · filed 2012-11-09 |